A STATEWIDE SURVEILLANCE SYSTEM FOR ANTIMICROBIAL-RESISTANT BACTERIA - NEW-JERSEY

被引:0
|
作者
PAUL, SM
FINELLI, L
CRANE, GL
SPITALNY, KC
机构
[1] NEW JERSEY DEPT HLTH,DIV EPIDEMIOL ENVIRONM,TRENTON,NJ 08625
[2] NEW JERSEY DEPT HLTH,OCCUPAT HLTH SERV,TRENTON,NJ 08625
来源
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY | 1995年 / 16卷 / 07期
关键词
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
OBJECTIVES: To determine the validity of an active, hospital laboratory isolate-based surveillance system in estimating rates of infection and to evaluate the use of surveillance data in describing institutional risk factors for increased rates of infection. Methicillin-resistant Staphylococcus aureus (MRSA) was chosen as the prototype organism for these evaluations. DESIGN: Correlation Study: linear regression analysis and Student's t test were used to evaluate the correlation between number of MRSA isolates and number of MRSA infections in acute-care hospitals. Cross-Sectional Study: Student's t test, analysis of variance, and multiple linear regression analysis were used to evaluate the association between mean annual rate of MRSA blood isolates and institutional risk factors for increased rates of infection. SETTING: Acute-care hospitals, New Jersey. RESULTS: The number of MRSA blood isolates was significantly correlated with MRSA blood infections (R, 0.78; P<.01) and provided a good proxy measure for number of infections. Multivariate analysis demonstrated hospital location in the inner city (P=.02) and number of occupied beds (P<.01) to be independently associated with increased mean annual rates of MRSA blood isolates in acute-care hospitals. CONCLUSIONS: This surveillance system is a valid tool for the estimation of institutional rates of infection and for the determination of institutional risk factors for increased rates of infection. It is ideal for further population-based investigations of antimicrobial-resistant bacteria (Infect Control Hosp Epidemiol 1995;16:385-390).
引用
收藏
页码:385 / 390
页数:6
相关论文
共 50 条
  • [1] A statewide surveillance system for antibiotic-resistant bacteria: The New Jersey Department of Health - Reply
    Lorian, V
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 1996, 17 (06): : 345 - 345
  • [2] Transmission Surveillance for Antimicrobial-Resistant Organisms in the Health System
    Pitout, Johann D. D.
    MICROBIOLOGY SPECTRUM, 2018, 6 (05):
  • [3] Secular trends in bloodstream infection caused by antimicrobial-resistant bacteria in New Jersey hospitals, 1991 to 1995
    Tokars, JI
    Paul, SM
    Crane, GL
    Cetron, MS
    Finelli, L
    Jarvis, WR
    AMERICAN JOURNAL OF INFECTION CONTROL, 1997, 25 (05) : 395 - 400
  • [4] Epidemiological surveillance cultures in antimicrobial-resistant bacteria causing nosocomial infection
    Cano, Maria Eliecer
    Dominguez, M. Angeles
    Ezpeleta, Carmen
    Padilla, Belen
    de Arellano, Encarnacion Ramirez
    Martinez-Martinez, Luis
    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2008, 26 (04): : 220 - 229
  • [5] SPEECH EDUCATION IN NEW-JERSEY - A STATEWIDE SURVEY
    EISENSTADT, AA
    ARNOLD, RG
    SPEECH TEACHER, 1957, 6 (03): : 188 - 192
  • [6] TOWARDS A STATEWIDE COMPOSTING PROGRAM IN NEW-JERSEY
    BOLAN, MP
    NIESWAND, GH
    SINGLEY, ME
    COMPOST SCIENCE-LAND UTILIZATION, 1978, 19 (05): : 30 - 35
  • [7] Antimicrobial-resistant bacteria in international travelers
    Sridhar, Sushmita
    Turbett, Sarah E.
    Harris, Jason B.
    LaRocque, Regina C.
    CURRENT OPINION IN INFECTIOUS DISEASES, 2021, 34 (05) : 423 - 431
  • [8] Antimicrobial-resistant bacteria in the community setting
    Furuya, EY
    Lowy, FD
    NATURE REVIEWS MICROBIOLOGY, 2006, 4 (01) : 36 - 45
  • [9] Antimicrobial-resistant bacteria in the community setting
    E. Yoko Furuya
    Franklin D. Lowy
    Nature Reviews Microbiology, 2006, 4 : 36 - 45
  • [10] A Surveillance Study of Culturable and Antimicrobial-Resistant Bacteria in Two Urban WWTPs in Northern Spain
    Pino-Hurtado, Mario Sergio
    Fernandez-Fernandez, Rosa
    Campana-Burguet, Allelen
    Gonzalez-Azcona, Carmen
    Lozano, Carmen
    Zarazaga, Myriam
    Torres, Carmen
    ANTIBIOTICS-BASEL, 2024, 13 (10):